Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-12-06 Klickstein Lloyd Chief Innovation Officer Grant or award −16,888 16,888
2019-12-06 Mannick Joan Chief Medical Officer Grant or award +118,222 1,404,585
2019-12-06 Mannick Joan Chief Medical Officer Grant or award · Stock Option (Right to Buy) +88,667 88,667
2019-12-06 MCCABE JOHN J Vice President, Finance Grant or award +12,867 12,867
2019-12-06 MCCABE JOHN J Vice President, Finance Grant or award · Stock Option (Right to Buy) +16,400 16,400
2019-12-06 Klickstein Lloyd Chief Scientific Officer Grant or award +118,222 118,222
2019-12-06 Klickstein Lloyd Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +88,667 88,667
2019-12-06 Schor Chen President and CEO Grant or award +344,000 669,000
2019-12-06 Schor Chen President and CEO Grant or award · Stock Option (Right to Buy) +258,000 258,000
2019-11-15 PureTech Health LLC 10% owner Sale −531,040 $1.25 $662K 9,269,356
2019-05-13 Klickstein Lloyd Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +295,000 295,000
2019-05-08 Sullivan Lynne Marie Director Grant or award · Stock Option (Right to Buy) +14,414 14,414
2019-05-08 SILVERSTEIN JONATHAN Director Grant or award · Stock Option (Right to Buy) +14,414 14,414
2019-05-08 Grissinger Michael Director Grant or award · Stock Option (Right to Buy) +14,414 14,414
2019-05-08 Chodakewitz Jeffrey Director Grant or award · Stock Option (Right to Buy) +14,414 14,414
2019-05-08 FONTEYNE PAUL R. Director Grant or award · Stock Option (Right to Buy) +14,414 14,414
2019-05-08 Steinberg David Adam Director Grant or award · Stock Option (Right to Buy) +14,414 14,414
2019-02-27 Mannick Joan Chief Medical Officer Grant or award · Stock Option (Right to Buy) +93,000 93,000
2019-02-27 Schor Chen President and CEO Grant or award · Stock Option (Right to Buy) +214,000 214,000
2019-02-27 Manning Meredith Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +26,000 26,000

Page 27 of 29 · 569 trades